UNI-PHARMA brings SALOSPIR, the first acetylsalicylic acid product launched in Europe in the form of enteric-coated tablets, in 80 – 1,000® mg doses.

T4®, a product for the treatment of thyroid gland diseases, is a specialized product available in 13 different strengths in individualized dosage regimens.

APOTEL®, introduced to the market in 1992, was the world’s first injectable formulation of paracetamol, based on a method of paracetamol solubilization, developed by UNI-PHARMA.

In 1998 UNI-PHARMA obtained the European Patent for injectable paracetamol solutions and paracetamol in combination with other active substances.

Miniflam, a non-steroidal anti-inflammatory drug in the form of a diclofenac gel suitable for topical administration, is granted a European patent in 2005.

The stable aqueous paracetamol solution of, Apotel Max, suitable for injectable administration, is granted a European patent.

During the biggest economic recession that Greece has experienced post-war, the company’s management, headed by Mrs. Ioulia and Mrs. Eirini Tseti, begins the ambitious plan for the creation of its new bioclimatic plant in Kato Kifissia.

Uniburn, formulated with a combination of sucralfate, hyaluronic acid, and natural moisturizing agents such as natural yogurt, suitable for topical administration, is granted a European patent.

The necessary validation works are completed, so as to put basic production lines into operation. The new facilities are a model of bioclimatic implementation, designed to taking full advantage of the climatic conditions for their operation while reducing any energy-consuming process, in full harmony with the natural environment.

In 2016, UNI-PHARMA joined the UN Global Compact, the United Nations’ global initiative, actively supporting its 10 principles across four thematic areas: human rights, labor standards, environment, and anti-corruption. Notably, UNI-PHARMA is internationally recognized as an official supplier to the United Nations, UNICEF, and the World Health Organization (WHO).

The election of the CEO of OFET (Tseti Group of Pharmaceutical Companies), Mrs. Ioulia Tseti to the General Council of the Hellenic Federation of Enterprises is expected to unfold in accordance with her firm belief that we can and must keep the bright minds in our country – after the bleeding of the brain drain and with a view to building a new Greece with strong characteristics of growth and extroversion, based on healthy businesses!

In March 2019, Mrs. Ioulia Tseti was included in the list of the 30 Most Powerful Women in Greece 2019 of Fortune Hellas magazine.

The Tseti Pharmaceutical Group (OFET) was distinguished at the annual Creative Greece 2019 awards. During the award ceremony, the Group’s President and CEO, Ioulia Tseti, announced the establishment of a new medicinal plant extracts unit, Uniherbo, which will also serve as a Research Institute for students.

Honorary Award to Mrs. Ioulia and Mrs. Eirini Tseti for their overall contribution to the pharmaceutical industry, health and business from BEST IN PHARMACY 2019.

The renovation – maintenance of the first historic UNI-PHARMA factory in Kifissia is completed.

In 2019, UNI-PHARMA embraced the Sustainable Development Goals (SDGs) and integrated sustainability standards into its daily operations. The company’s leadership aims to further enhance its social impact, while simultaneously reducing its environmental and energy footprint, remaining committed to effective corporate governance and ethical business practices.

Environment and Green Development Award of the Athens Chamber of Commerce and Industry to UNI-PHARMA.

Tseti Group of Pharmaceutical Companies CEO, Mrs. Ioulia Tseti, achieved an important distinction – overall for our country and the field of sustainable development –, as she was elected President of the first Board of Directors of Global Compact Hellas, which is the Local Network of the UN Global Compact.

UNI-PHARMA was among the 18 best companies in the country out of a total of 8,000 at the Growth Awards competition, which took place on the evening of Monday, February 17, 2020 at the Athens Concert Hall (Megaron). The Awards, which best highlight healthy entrepreneurship, innovation and excellence in a challenging environment are organized by Grant Thornton and Eurobank.

To UNI-PHARMA’s Repel products, following a vote by iatronet, at the 11th Health Expo Athens.

In the most serious public health crisis the planet has known, Mrs. Ioulia Tseti donates to the Greek and Cypriot health system Unikinon – with chloroquine as an active ingredient, to help patients hospitalized with SARS CoV-2. The production of the drug began almost immediately at the UNI-PHARMA facilities in Kato Kifissia. In the first pandemic wave, chloroquine was cited as a possible successful treatment to tackle the pandemic. Donations amounted to EUR 24 million free Unikinon doses for the (Hellenic) National Health System and 60,000 doses for the Cypriot health system.

The Tseti Pharmaceutical Group (OFET) won a total of seven distinctions (Gold, Silver, and Platinum) at the Best in Pharmacy Awards 2020, including the highest honor, “Pharmacy Company of the Year,” awarded to UNI-PHARMA. UNI-PHARMA also received two Gold Awards for being a leading socially responsible company, recognized for its large donations of Unikinon (chloroquine) and antiseptics during the SARS COVID-19 pandemic. Additionally, UNI-PHARMA received two Silver Awards, one for being a top Green company and another for the launch of the TONOSAN dietary supplement line.

Since December 7, 2020, Tsetis Group of Pharmaceutical Companies has been in the leading group of The Most Sustainable Companies in Greece 2020, the 25 companies with the greatest sustainable growth. This is a technical evaluation, carried out by the executives of the Quality Net Foundation Network that makes the Most Sustainable Companies title for the OFET industries, UNI-PHARMA and InterMed, particularly important.

The Tsetis Group of Pharmaceutical Companies (OFET) was once again honored with the Diamonds of the Greek Economy Award, organized by New Times Publishing Group. OFET was recognized for its ongoing investments in a challenging and demanding environment, its significant financial growth, and its targeted corporate responsibility strategy. This strategy encompasses initiatives for society, the environment, science, research, and supporting the next generation.

Ioulia Tseti, President of UNI-PHARMA, was honored as World Woman Leader of Pharmaceutical Industry & Social Contribution at the Who is Who International Awards 2021.

On September 27, 2021, Julia Tseti, via the Kleon Tsetis NPO Foundation, made a large donation of an interactive, 100 seats amphitheater to the School of Pharmacy of the National and Kapodistrian University of Athens, amounting to 120,000 euros. The donation symbolically coincides with the celebration of the 200th anniversary of the Greek Revolution.

Working with UNHCR and UNHCR Representative in Greece, Ms. Maria Clara Martin, to activate targeted actions for refugees. The aim is for these vulnerable groups to be able to integrate into both society and the labor market.

The Tsetis Group of Pharmaceutical Companies announced groundbreaking collaborations in the field of biotechnology with two of Greece’s leading institutes: the Institute of Molecular Biology and Biotechnology in Crete and the Institute of Biomedical Research in Ioannina. Both institutes operate under the umbrella of the Foundation for Research and Technology-Hellas (FORTH).

This is the highest acclaim of the academic community towards Mrs. Ioulia Tseti, honoring her multiannual research work, but also her ceaseless and tireless actions in aid of the society, the younger generation, and the environment. The investiture ceremony took place in the presence of the Rector’s Authorities, His Eminence the Metropolitan of Arta, professors and students, executives of the Tsetis Group, representatives of the business world and the press.

UNI-PHARMA was distinguished with the ACCI Business Award for Corporate Social Responsibility on Thursday June 22. The President and CEO of the Tsetis Pharmaceutical Companies Ioulia Tseti as well as the CFO Eirini Tseti received the award by the Prime Minister, Kyriakos Mitsotakis, in the presence of the President of The ACCI, Yiannis Bratakos.

Ioulia Tseti received a distinction for her continuous and targeted efforts towards society, research, the younger generation, and the environment. The award was granted by the Scientific and Organizing Committee of the 8th International Summer University in Kastelorizo.

UNI-PHARMA has been certified as a Top Employer 2023 in Greece by the Top Employers Institute, the leading global authority on recognizing and promoting excellence in human resources strategies. UNI-PHARMA and InterMed become the first Greek pharmaceutical companies to achieve this prestigious certification.

UNI-PHARMA President and CEO Ioulia Tseti has been named one of the Inspirational Mentors, a prestigious initiative established by the non-profit educational organization Junior Achievement Greece. This program highlights 70 influential figures from Greece who inspire and empower the next generation. As part of her mentorship, the CEO of OFET collaborated with high school students from the 2nd Vocational High School (EPAL) in Kozani. Together, they worked on creating their own virtual business startup as part of the “Virtual Enterprise – Company Program” competition.

UNI-PHARMA participated in the Sustainability Performance Directory 2023, an initiative by the Quality Net Foundation, and following a thorough evaluation, was ranked among the 35 leading companies shaping the business map of sustainable development in Greece. This recognition was based on the company’s performance in three key criteria: Environment – Society – Corporate Governance (ESG).

UNI-PHARMA President and CEO Ioulia Tseti was honored for her significant contributions to modern women’s entrepreneurship at the 2nd Women’s Conference titled “Modern Women / Successful Managers”, organized by Business Review Magazine. The conference was held under the auspices of the Athens Chamber of Commerce and Industry (ACCI), the General Secretariat for Demographic and Family Policy and Gender Equality, the Greek Association of Women Entrepreneurs (EGE), and the initiative Ella-dika Mas.

The Tsetis Group of Pharmaceutical Companies received the honorary distinction of “Honored Pharmaceutical Innovation Company” at the Prix Galien 2023 awards. This recognition celebrates the company’s advancements in pharmaceutical innovation and its significant contribution to the Greek economy.

UNI-PHARMA proudly supports the mission of the “Exelixi Zois” (Evolution Of Life) organization, which focuses on the care and holistic support of adolescents, young adults, and individuals up to 25 years old transitioning from institutional care environments. The organization’s support is provided through a combination of programs, including educational initiatives, psychosocial empowerment, career guidance, access to culture and sports, and semi-autonomy and autonomy training. These efforts aim to foster their creative integration into society, helping them leave behind the challenges of institutional care and build a brighter future.

Following a comprehensive evaluation across various key business and financial indicators, UNI-PHARMA was honored as a Growth Winner at the Growth Awards 2023, an event organized by Grant Thornton and Eurobank to recognize excellence in growth and competitiveness. The pharmaceutical company stood out among 8,000 businesses nationwide, being one of the six companies with the most significant impact in terms of growth and international outreach.

The pharmaceutical companies UNI-PHARMA and InterMed have been recognized as Top Employers in Greece for the second consecutive year by the Top Employers Institute. This prestigious distinction highlights their unwavering commitment to building a better workplace by prioritizing employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected organizational culture.

UNI-PHARMA President and CEO Ioulia Tseti collaborated with the students of the Vocational High School (EPAL) in Mykonos, guiding them in the creation of a virtual business. This initiative reflects her dedication to inspiring and empowering young minds to develop entrepreneurial skills and creative thinking.

The Tsetis Group of Pharmaceutical Companies (OFET) was honored with the “Kotinos Olympic Wreath” Responsibility Distinction by EBEN.GR – European Business Ethics Network. The award was given during the Responsible Management Excellence Awards 2024, held on May 29. OFET stood out among companies operating in Greece, both in the private and public sectors, that were evaluated, scored, and certified based on EBEN’s Responsible Management Excellence model.

On Thursday, June 13, 2024, Ioulia Tseti, President of UNI-PHARMA, was awarded the title of Honorary Doctor of Pharmacy by the University of Patras. This prestigious recognition highlights her significant contributions to the field of pharmacy and her enduring impact on the pharmaceutical industry.

UNI-PHARMA received an honorary distinction from the Aristotle University of Thessaloniki (AUTh) in recognition of its contributions to funding research and innovation at the university. This accolade underscores UNI-PHARMA’s commitment to supporting academic excellence and advancing scientific progress.

On October 8, 2024, Ioulia Tseti, President of UNI-PHARMA, was honored as Woman of the Year 2024 during the CPHI 2024 exhibition in Milan. CPHI, a cornerstone event for the global pharmaceutical industry for over 35 years, brings together health sector leaders from around the world. Ioulia Tseti received the award in recognition of her dedication to innovation, sustainable development, and social responsibility. She was celebrated as a “true visionary and pioneer in the field, leaving a significant mark on the global pharmaceutical industry.”.

UNI-PHARMA has been honored as a True Leader of the Greek economy, a distinction awarded by ICAP CRIF. This recognition is the result of an in-depth analysis conducted by ICAP experts, which evaluated the financial performance and EBITDA data of the 500 most profitable companies in Greece for 2023. UNI-PHARMA was distinguished for its performance and strategic growth among the 200 corporate groups in Greece with the highest EBITDA profits.

For the third consecutive year, UNI-PHARMA and InterMed have been certified as Top Employers in Greece by the Top Employers Institute, the leading global organization dedicated to recognizing and promoting excellence in human resources strategies. This distinction highlights their unwavering commitment to creating a better workplace, with a strong focus on employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected work culture.